Search Results 691-700 of 17136 for treatment resistant depression

  1. Ixazomib Citrate in Treating Patients With Relapsed Multiple Myeloma That Is Not Refractory to Bortezomib - Mayo Clinic

    ... resistant to bortezomib (refractory). Ixazomib citrate may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth ...

  2. Clinical trials - Oncology (Medical)

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.

  3. Alzheimer's disease - Diagnosis and treatment - Mayo Clinic

    Cholinesterase inhibitors may improve symptoms related to behavior, such as agitation or depression. The medicines are taken by mouth or through a patch on the ...

  4. A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer - Mayo Clinic

    Clinical Trials · A Study of the Combination of ACP-196 and Pembrolizumab in Subjects with Platinum-Refractory Metastatic Bladder Cancer · More about research at ...

  5. Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. - Mayo Clinic

    Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma.

  6. Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) - Mayo Clinic

    Clinical Trials · Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone ...

  7. A Comparison of Nursing Assessment and a Continuous Noninvasive Respiratory Volume Monitor for the Identification of Respiratory Depression and Obstructive Breathing Patterns During Phase I Anesthesia Recovery - Mayo Clinic

    The purpose of this study is to compare respiratory volume monitor (RVM) assessments of apnea and Low MV to nursing assessments of respiratory depressive events ...

  8. A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) ...

  9. Ruth Nearly Lost Her Life to Depression - Mayo Clinic News Network

    Read the script. Putting Kieran's Heart Back Where it Belongs · Mayo Clinic Q and A: “Aging spots” typically don't require treatment. Related Articles. Health ...

  10. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell ...